Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Quinnova Pharmaceuticals Including Sarms, Peptides and More revenue
Quinnova Pharmaceuticals Including Sarms, Peptides and More's revenue is $5.3 million.
What is Quinnova Pharmaceuticals Including Sarms, Peptides and More's revenue?
- Quinnova Pharmaceuticals Including Sarms, Peptides and More has 75 employees, and the revenue per employee ratio is $70,667.
- Quinnova Pharmaceuticals Including Sarms, Peptides and More peak revenue was $5.3M in 2024.
On this page
Zippia finds jobs where you're a top candidate and applies on your behalf.
Quinnova Pharmaceuticals Including Sarms, Peptides and More financing
Quinnova Pharmaceuticals Including Sarms, Peptides and More received early financing of $13.6M on 2006-11-28.
| Series | Round size | Date |
|---|---|---|
| Series A | $13.6M | 11/2006 |
| Series B | $17.4M | 10/2009 |
| Convertible Note | $300K | 09/2010 |
Quinnova Pharmaceuticals Including Sarms, Peptides and More investors
| Investors | Security type |
|---|---|
| Thomas, McNerney & Partners | Series A |
| H.I.G. Capital, Inc. | Series A |
| Thomas, McNerney & Partners | Series B |
| H.I.G. Capital, Inc. | Series B |
| SAFEGUARD SCIENTIFICS INC | Series B |
Quinnova Pharmaceuticals Including Sarms, Peptides and More competitors
Quinnova Pharmaceuticals Including Sarms, Peptides and More's top competitor, Salix Pharmaceuticals, earned an annual revenue of $1.1B.
Quinnova Pharmaceuticals Including Sarms, Peptides and More's smallest competitor is PruGen Pharmaceuticals with revenue of $670.0K last year.
| Company name | Average salary | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| Salix Pharmaceuticals | - | $1.1B | 1,000 | - |
| Mission Pharmacal | - | $140.0M | 750 | - |
| Aqua Pharmaceuticals | - | $8.6M | 71 | - |
| Primus Pharmaceuticals | - | $17.5M | 50 | - |
| Shionogi | - | $50.0M | 6,082 | - |
| Insightra Medical | - | $3.1M | 31 | - |
| Topix Pharmaceuticals | - | $11.5M | 150 | - |
| Pernix Therapeutics Holdings | - | $146.1M | 171 | - |
| Zogenix | - | $81.7M | 90 | - |
| Santarus | - | $218.0M | 290 | - |
Quinnova Pharmaceuticals Including Sarms, Peptides and More revenue FAQs
Search for jobs
Related company revenues
Working at related companies
Related company jobs
Most in demand jobs
Zippia gives an in-depth look into the details of Quinnova Pharmaceuticals Including Sarms, Peptides and More, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Quinnova Pharmaceuticals Including Sarms, Peptides and More. The employee data is based on information from people who have self-reported their past or current employments at Quinnova Pharmaceuticals Including Sarms, Peptides and More. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Quinnova Pharmaceuticals Including Sarms, Peptides and More. The data presented on this page does not represent the view of Quinnova Pharmaceuticals Including Sarms, Peptides and More and its employees or that of Zippia.
Quinnova Pharmaceuticals Including Sarms, Peptides and More may also be known as or be related to Quinnova Pharmaceuticals, Quinnova Pharmaceuticals Including Sarms, Peptides and More and Quinnova Pharmaceuticals, Inc.